Collin Tokheim is an Associate Director in Oncology Data Science & AI at AstraZeneca with 13 years of experience applying machine learning and bioinformatics to cancer discovery and drug development. He has led small interdisciplinary teams to build computational frameworks for Targeted Protein Degradation, contributed to multiple lead optimization and investment decisions, and proactively discovered new therapeutic targets advanced into validation and a drug program. His postdoctoral and graduate work produced machine learning methods and high-impact publications (Cell, Molecular Cell, Nature Communications) that link somatic mutations and proteomic changes to cancer biology. Based in Waltham, MA, Collin blends deep methodological rigor with translational impact—often turning complex multi-omic datasets into actionable insights for oncology programs.
13 years of coding experience
10 years of employment as a software developer
Doctor of Philosophy - PhD Bioengineering and Biomedical Engineering, Doctor of Philosophy - PhD Bioengineering and Biomedical Engineering at The Johns Hopkins University School of Medicine
Bachelor of Science in Engineering (BSE) Biomedical Engineering, Bachelor of Science in Engineering (BSE) Biomedical Engineering at University of Iowa
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.